These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7833158)

  • 1. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer.
    González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacon I; Garrido P; Colmenarejo A
    Eur J Cancer; 1994; 30A(11):1733-4. PubMed ID: 7833158
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation.
    Chao Y; Teng HC; Hung HC; King KL; Li CP; Chi KH; Yen SH; Chang FY
    Jpn J Clin Oncol; 2000 Mar; 30(3):122-5. PubMed ID: 10798538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
    González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacón I; Garrido P; Colmenarejo A; Ordóñez A; Zamora P
    Cancer Chemother Pharmacol; 1995; 36(3):255-8. PubMed ID: 7781148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
    Chi KH; Chao Y; Chan WK; Lo SS; Chen SY; Yen SH; Chen KY; Wu CW; Lee SD; Lui WY
    Br J Cancer; 1998 Jun; 77(11):1984-8. PubMed ID: 9667679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of preoperative FPL (5-fluorouracil, cisplatin, leucovorin) therapy on patients with primary unresectable advanced gastric cancer].
    Tsujinaka T; Kato T; Shiozaki H; Murata A; Nishijima J; Kobayashi K; Inoue M; Miyata M; Kido Y; Mori T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):303-6. PubMed ID: 8434971
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of metastatic gastric cancer.
    Wils J
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():395-8. PubMed ID: 10895185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Curative resection of advanced gastric cancer responding to preoperative chemotherapy--a case report].
    Kobayashi M; Kasakura Y; Fujii M; Mochizuki F; Kochi M; Eguchi T; Imai S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):527-30. PubMed ID: 11329789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemotherapy for advanced gastric cancer using FLEP therapy].
    Mochizuki F; Fujii M; Kasakura Y; Kochi M; Imai S; Eguchi T; Tsuneda Y; Kanamori N; Kaiga T; Kobayashi M
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1812-5. PubMed ID: 11086418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.
    Guimbaud R; Louvet C; Ries P; Ychou M; Maillard E; André T; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Boucher E; Rebischung C; Hammel P; Rougier P; Bedenne L; Bouché O
    J Clin Oncol; 2014 Nov; 32(31):3520-6. PubMed ID: 25287828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
    J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
    [No Abstract]   [Full Text] [Related]  

  • 13. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
    Al-Batran SE; Hofheinz RD; Pauligk C; Kopp HG; Haag GM; Luley KB; Meiler J; Homann N; Lorenzen S; Schmalenberg H; Probst S; Koenigsmann M; Egger M; Prasnikar N; Caca K; Trojan J; Martens UM; Block A; Fischbach W; Mahlberg R; Clemens M; Illerhaus G; Zirlik K; Behringer DM; Schmiegel W; Pohl M; Heike M; Ronellenfitsch U; Schuler M; Bechstein WO; Königsrainer A; Gaiser T; Schirmacher P; Hozaeel W; Reichart A; Goetze TO; Sievert M; Jäger E; Mönig S; Tannapfel A
    Lancet Oncol; 2016 Dec; 17(12):1697-1708. PubMed ID: 27776843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intensive chemotherapy and radical surgery for incurable gastric cancer.
    Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Ohashi Y; Yanagisawa A
    Ann Surg Oncol; 1997; 4(3):203-8. PubMed ID: 9142380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
    Amini A; Sanati H
    Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
    Chen CH; Yang CT; Chang WJ; Liaw CC; Tsao TC
    Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):220-6. PubMed ID: 10493026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy of gastric carcinoma].
    Parisi V; Daniele B; Perrone F; DeMaio L; Delrio P; Palaia R
    Suppl Tumori; 2002; 1(3):S27-9. PubMed ID: 12415782
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.